Estudo de coorte baseado em registro na Finlândia | Efetividade no mundo real de doses de antipsicóticos para prevenção de recorrência em pacientes com primeiro episódio de esquizofrenia.

Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study – The Lancet Psychiatry (link para o resumo – $ para o texto completo)

Comentário no Twitter (fio – clique para saber mais)

cohort study in 1st-episode schizophrenia: The effectiveness of antipsychotics for relapse prevention decreased after the 2nd relapse. The aHR for rehospitalisation with AP use versus non-use increased from 0·42 to 0·78 after the 2nd relapse (p<0·0001) https://t.co/IBhDPNJJpe?

— PfOL (@psychopharmacol) March 18, 2022